Natural History of Bladder Cancer

Non-Muscle-Invasive Bladder Cancer (NMIBC)

Approximately 70-75% of newly diagnosed bladder cancers are non-muscle-invasive disease, consisting of exophytic papillary tumors confined to the mucosa, lamina propria, or flat high-grade lesions, according to the National Comprehensive Cancer Network 1, 2, 3
These tumors are friable with high propensity for bleeding, typically presenting as painless hematuria in >80% of patients, as reported by the Annals of Oncology 4, 5
The hallmark of NMIBC natural history is the tendency to recur in the bladder, with recurrences occurring either at the same stage or progressing to more advanced stage, as stated by the National Comprehensive Cancer Network 1, 2
An estimated 31-78% of patients with tumors confined to the mucosa or submucosa will experience recurrence or new occurrence of urothelial carcinoma within 5 years, with the wide range reflecting variation based on initial stage, grade, size, and multiplicity, according to the National Comprehensive Cancer Network 1, 2

Most diagnosed cases of MIBC (80-90%) present as primary invasive bladder cancer, while only 10-15% have a history of NMIBC, as reported by the Annals of Oncology 4, 5, 7
Approximately 70% of patients with bladder cancer are >65 years of age at diagnosis, according to the Annals of Oncology 4, 5, 8
Carcinoma in situ (CIS) represents a particularly aggressive variant with worse prognosis, especially when multifocal, requiring more intensive management, as stated by Praxis Medical Insights 6

The depth of invasion is the most important determinant of prognosis and treatment of localized bladder cancer, with the transition from non-muscle-invasive to muscle-invasive disease representing a critical inflection point in natural history, as reported by the National Comprehensive Cancer Network 1, 2